Skip to main content

Advertisement

Log in

Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review

  • Review
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Anal fistulas continue to be a problem for patients and surgeons alike despite scientific advances. While patient and anatomical characteristics are important to surgeons who are evaluating patients with anal fistulas, their development and persistence likely involves a multifaceted interaction of histological, microbiological, and molecular factors. Histological studies have shown that anal fistulas are variably epithelialized and are surrounded by dense collagen tissue with pockets of inflammatory cells. Yet, it remains unknown if or how histological differences impact fistula healing. The presence of a perianal abscess that contains gut flora commonly leads to the development of anal fistula. This implies a microbiological component, but bacteria are infrequently found in chronic fistulas. Recent work has shown an increased expression of proinflammatory cytokines and epithelial to mesenchymal cell transition in both cryptoglandular and Crohn’s perianal fistulas. This suggests that molecular mechanisms may also play a role in both fistula development and persistence. The aim of this study was to examine the histological, microbiological, molecular, and host factors that contribute to the development and persistence of anal fistulas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Abcarian H (2014) Anal fistula principles and management. Springer, New York

    Book  Google Scholar 

  2. Nelson R (2002) Anorectal abscess fistula: what do we know? Surg Clin North Am 82(6):1139–1151 (v–vi)

    Article  PubMed  Google Scholar 

  3. Sainio P (1984) Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Ann Chir Gynaecol 73(4):219–224

    CAS  PubMed  Google Scholar 

  4. Kronborg O (1985) To lay open or excise a fistula-in-ano: a randomized trial. Br J Surg 72(12):970

    Article  CAS  PubMed  Google Scholar 

  5. Hebjorn M, Olsen O, Haakansson T, Andersen B (1987) A randomized trial of fistulotomy in perianal abscess. Scand J Gastroenterol 22(2):174–176

    Article  CAS  PubMed  Google Scholar 

  6. Tang CL, Chew SP, Seow-Choen F (1996) Prospective randomized trial of drainage alone vs. drainage and fistulotomy for acute perianal abscesses with proven internal opening. Dis Colon Rectum 39(12):1415–1417

    Article  CAS  PubMed  Google Scholar 

  7. Ho YH, Tan M, Chui CH, Leong A, Eu KW, Seow-Choen F (1997) Randomized controlled trial of primary fistulotomy with drainage alone for perianal abscesses. Dis Colon Rectum 40(12):1435–1438

    Article  CAS  PubMed  Google Scholar 

  8. Ho YH, Tan M, Leong AF, Seow-Choen F (1998) Marsupialization of fistulotomy wounds improves healing: a randomized controlled trial. Br J Surg 85(1):105–107. doi:10.1046/j.1365-2168.1998.00529.x

    Article  CAS  PubMed  Google Scholar 

  9. Oliver I, Lacueva FJ, Perez Vicente F, Arroyo A, Ferrer R, Cansado P, Candela F, Calpena R (2003) Randomized clinical trial comparing simple drainage of anorectal abscess with and without fistula track treatment. Int J Colorectal Dis 18(2):107–110. doi:10.1007/s00384-002-0429-0

    CAS  PubMed  Google Scholar 

  10. Pescatori M, Ayabaca SM, Cafaro D, Iannello A, Magrini S (2006) Marsupialization of fistulotomy and fistulectomy wounds improves healing and decreases bleeding: a randomized controlled trial. Colorectal Dis 8(1):11–14. doi:10.1111/j.1463-1318.2005.00835.x

    Article  CAS  PubMed  Google Scholar 

  11. Garcia-Aguilar J, Belmonte C, Wong WD, Goldberg SM, Madoff RD (1996) Anal fistula surgery. Factors associated with recurrence and incontinence. Dis Colon Rectum 39(7):723–729

    Article  CAS  PubMed  Google Scholar 

  12. Abbas MA, Jackson CH, Haigh PI (2011) Predictors of outcome for anal fistula surgery. Arch Surg 146(9):1011–1016. doi:10.1001/archsurg.2011.197

    Article  PubMed  Google Scholar 

  13. van Onkelen RS, Gosselink MP, Thijsse S, Schouten WR (2014) Predictors of outcome after transanal advancement flap repair for high transsphincteric fistulas. Dis Colon Rectum 57(8):1007–1011. doi:10.1097/DCR.0000000000000154

    Article  PubMed  Google Scholar 

  14. Mitalas LE, Dwarkasing RS, Verhaaren R, Zimmerman DD, Schouten WR (2011) Is the outcome of transanal advancement flap repair affected by the complexity of high transsphincteric fistulas? Dis Colon Rectum 54(7):857–862. doi:10.1007/DCR.0b013e31820eee2e

    Article  PubMed  Google Scholar 

  15. Cintron JR, Park JJ, Orsay CP, Pearl RK, Nelson RL, Sone JH, Song R, Abcarian H (2000) Repair of fistulas-in-ano using fibrin adhesive: long-term follow-up. Dis Colon Rectum 43(7):944–949 (discussion 949–950)

    Article  CAS  PubMed  Google Scholar 

  16. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16(5):585–601. doi:10.1111/j.1524-475X.2008.00410.x

    Article  PubMed  Google Scholar 

  17. Guo S, Dipietro LA (2010) Factors affecting wound healing. J Dent Res 89(3):219–229. doi:10.1177/0022034509359125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ramanujam PS, Prasad ML, Abcarian H, Tan AB (1984) Perianal abscesses and fistulas. A study of 1023 patients. Dis Colon Rectum 27(9):593–597

    Article  CAS  PubMed  Google Scholar 

  19. Chrabot CM, Prasad ML, Abcarian H (1983) Recurrent anorectal abscesses. Dis Colon Rectum 26(2):105–108

    Article  CAS  PubMed  Google Scholar 

  20. Hamadani A, Haigh PI, Liu IL, Abbas MA (2009) Who is at risk for developing chronic anal fistula or recurrent anal sepsis after initial perianal abscess? Dis Colon Rectum 52(2):217–221. doi:10.1007/DCR.0b013e31819a5c52

    Article  PubMed  Google Scholar 

  21. Devaraj B, Khabassi S, Cosman BC (2011) Recent smoking is a risk factor for anal abscess and fistula. Dis Colon Rectum 54(6):681–685. doi:10.1007/DCR.0b013e31820e7c7a

    Article  PubMed  Google Scholar 

  22. Read DR, Abcarian H (1979) A prospective survey of 474 patients with anorectal abscess. Dis Colon Rectum 22(8):566–568

    Article  CAS  PubMed  Google Scholar 

  23. McColl I (1967) The comparative anatomy and pathology of anal glands. Arris and Gale lecture delivered at the Royal College of Surgeons of England on 25th February 1965. Ann R Coll Surg Engl 40(1):36–67

    CAS  PubMed  PubMed Central  Google Scholar 

  24. El-Tawil AM (2012) Mechanism of non-specific-fistula-in-ano: hormonal aspects—review. Pathophysiology 19(1):55–59. doi:10.1016/j.pathophys.2011.07.004

    Article  CAS  PubMed  Google Scholar 

  25. Phillips RKS, Clark S (2014) Colorectal surgery. Companion to specialist surgical practice, 5th edn. Saunders/Elsevier, Edinburgh

    Google Scholar 

  26. Wang D, Yang G, Qiu J, Song Y, Wang L, Gao J, Wang C (2014) Risk factors for anal fistula: a case-control study. Tech Coloproctol 18(7):635–639. doi:10.1007/s10151-013-1111-y

    Article  CAS  PubMed  Google Scholar 

  27. Seow-Choen F, Ho JM (1994) Histoanatomy of anal glands. Dis Colon Rectum 37(12):1215–1218

    Article  CAS  PubMed  Google Scholar 

  28. Parks AG (1961) Pathogenesis and treatment of fistuila-in-ano. Br Med J 1(5224):463–469

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Herrmann GD, Desfosses L (1880) La sur la muquese de la region cloacle du rectum. CR Acad Sci 111(90):1301–1302

    Google Scholar 

  30. Eykyn SJ, Grace RH (1986) The relevance of microbiology in the management of anorectal sepsis. Ann R Coll Surg Engl 68(5):237–239

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Toyonaga T, Matsushima M, Tanaka Y, Shimojima Y, Matsumura N, Kannyama H, Nozawa M, Hatakeyama T, Suzuki K, Yanagita K, Tanaka M (2007) Microbiological analysis and endoanal ultrasonography for diagnosis of anal fistula in acute anorectal sepsis. Int J Colorectal Dis 22(2):209–213. doi:10.1007/s00384-006-0121-x

    Article  PubMed  Google Scholar 

  32. Vogel JD, Johnson EK, Morris AM, Paquette IM, Saclarides TJ, Feingold DL, Steele SR (2016) Clinical practice guideline for the management of anorectal abscess, Fistula-in-Ano, and Rectovaginal Fistula. Dis Colon Rectum 59(12):1117–1133. doi:10.1097/DCR.0000000000000733

    Article  PubMed  Google Scholar 

  33. Magalhaes JG, Tattoli I, Girardin SE (2007) The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin Immunol 19(2):106–115. doi:10.1016/j.smim.2006.12.006

    Article  CAS  PubMed  Google Scholar 

  34. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871–890. doi:10.1016/j.cell.2009.11.007

    Article  CAS  PubMed  Google Scholar 

  35. Bataille F, Rohrmeier C, Bates R, Weber A, Rieder F, Brenmoehl J, Strauch U, Farkas S, Furst A, Hofstadter F, Scholmerich J, Herfarth H, Rogler G (2008) Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn’s disease. Inflamm Bowel Dis 14(11):1514–1527. doi:10.1002/ibd.20590

    Article  PubMed  Google Scholar 

  36. Scharl M, Rogler G (2014) Pathophysiology of fistula formation in Crohn’s disease. World J Gastrointest Pathophysiol 5(3):205–212. doi:10.4291/wjgp.v5.i3.205

    PubMed  PubMed Central  Google Scholar 

  37. Hofman P, Vouret-Craviari V (2012) Microbes-induced EMT at the crossroad of inflammation and cancer. Gut Microbes 3(3):176–185. doi:10.4161/gmic.20288

    Article  PubMed  PubMed Central  Google Scholar 

  38. Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW (2016) Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 176:38–68. doi:10.1016/j.trsl.2016.04.009

    Article  CAS  PubMed  Google Scholar 

  39. Ratto C, Litta F, Lucchetti D, Parello A, Boninsegna A, Arena V, Donisi L, Calapa F, Sgambato A (2016) Immunopathological characterization of cryptoglandular anal fistula: a pilot study investigating its pathogenesis. Colorectal Dis 18(12):O436–O444. doi:10.1111/codi.13527

    Article  CAS  PubMed  Google Scholar 

  40. van Koperen PJ, Wind J, Bemelman WA, Bakx R, Reitsma JB, Slors JF (2008) Long-term functional outcome and risk factors for recurrence after surgical treatment for low and high perianal fistulas of cryptoglandular origin. Dis Colon Rectum 51(10):1475–1481. doi:10.1007/s10350-008-9354-9

    Article  PubMed  Google Scholar 

  41. Gustafsson UM, Graf W (2006) Randomized clinical trial of local gentamicin-collagen treatment in advancement flap repair for anal fistula. Br J Surg 93(10):1202–1207. doi:10.1002/bjs.5398

    Article  CAS  PubMed  Google Scholar 

  42. Sonoda T, Hull T, Piedmonte MR, Fazio VW (2002) Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 45(12):1622–1628. doi:10.1097/01.DCR.0000037653.68665.E8

    Article  PubMed  Google Scholar 

  43. Zimmerman DD, Briel JW, Gosselink MP, Schouten WR (2001) Anocutaneous advancement flap repair of transsphincteric fistulas. Dis Colon Rectum 44(10):1474–1480

    Article  CAS  PubMed  Google Scholar 

  44. Sirikurnpiboon S, Awapittaya B, Jivapaisarnpong P (2013) Ligation of intersphincteric fistula tract and its modification: results from treatment of complex fistula. World J Gastrointest Surg 5(4):123–128. doi:10.4240/wjgs.v5.i4.123

    Article  PubMed  PubMed Central  Google Scholar 

  45. Zimmerman DD, Delemarre JB, Gosselink MP, Hop WC, Briel JW, Schouten WR (2003) Smoking affects the outcome of transanal mucosal advancement flap repair of trans-sphincteric fistulas. Br J Surg 90(3):351–354. doi:10.1002/bjs.4044

    Article  CAS  PubMed  Google Scholar 

  46. Ellis CN, Clark S (2007) Effect of tobacco smoking on advancement flap repair of complex anal fistulas. Dis Colon Rectum 50(4):459–463. doi:10.1007/s10350-006-0829-2

    Article  PubMed  Google Scholar 

  47. Ellis CN, Rostas JW, Greiner FG (2010) Long-term outcomes with the use of bioprosthetic plugs for the management of complex anal fistulas. Dis Colon Rectum 53(5):798–802. doi:10.1007/DCR.0b013e3181d43b7d

    Article  PubMed  Google Scholar 

  48. Abcarian AM, Estrada JJ, Park J, Corning C, Chaudhry V, Cintron J, Prasad L, Abcarian H (2012) Ligation of intersphincteric fistula tract: early results of a pilot study. Dis Colon Rectum 55(7):778–782. doi:10.1097/DCR.0b013e318255ae8a

    Article  PubMed  Google Scholar 

  49. Seow-Choen F, Hay AJ, Heard S, Phillips RK (1992) Bacteriology of anal fistulae. Br J Surg 79(1):27–28

    Article  CAS  PubMed  Google Scholar 

  50. Lunniss PJ, Faris B, Rees HC, Heard S, Phillips RK (1993) Histological and microbiological assessment of the role of microorganisms in chronic anal fistula. Br J Surg 80(8):1072

  51. de San Ildefonso PA, Maruri CI, Facal AC, Torres J, Casal JE (2002) Bacteriology of anal fistulae. Rev Esp Enferm Dig 94(9):533–536

    Google Scholar 

  52. Tozer PJ, Rayment N, Hart AL, Daulatzai N, Murugananthan AU, Whelan K, Phillips RK (2015) What role do bacteria play in persisting fistula formation in idiopathic and Crohn’s anal fistula? Colorectal Dis 17(3):235–241. doi:10.1111/codi.12810

    Article  CAS  PubMed  Google Scholar 

  53. van Onkelen RS, Mitalas LE, Gosselink MP, van Belkum A, Laman JD, Schouten WR (2013) Assessment of microbiota and peptidoglycan in perianal fistulas. Diagn Microbiol Infect Dis 75(1):50–54. doi:10.1016/j.diagmicrobio.2012.09.012

    Article  PubMed  Google Scholar 

  54. Kiehne K, Fincke A, Brunke G, Lange T, Folsch UR, Herzig KH (2007) Antimicrobial peptides in chronic anal fistula epithelium. Scand J Gastroenterol 42(9):1063–1069. doi:10.1080/00365520701320489

    Article  CAS  PubMed  Google Scholar 

  55. van Onkelen RS, Gosselink MP, van Meurs M, Melief MJ, Schouten WR, Laman JD (2016) Pro-inflammatory cytokines in cryptoglandular anal fistulas. Tech Coloproctol 20(9):619–625. doi:10.1007/s10151-016-1494-7

    Article  PubMed  PubMed Central  Google Scholar 

  56. Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR (1997) A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn’s disease. J Immunol 159(12):6276–6282

    CAS  PubMed  Google Scholar 

  57. Marzo M, Felice C, Pugliese D, Andrisani G, Mocci G, Armuzzi A, Guidi L (2015) Management of perianal fistulas in Crohn’s disease: an up-to-date review. World J Gastroenterol 21(5):1394–1403. doi:10.3748/wjg.v21.i5.1394

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ (2004) Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 350(9):876–885. doi:10.1056/NEJMoa030815

    Article  CAS  PubMed  Google Scholar 

  59. Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD, Pollack PF (2007) Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: the CHARM trial. Gastroenterology 132(1):52–65. doi:10.1053/j.gastro.2006.11.041

    Article  CAS  PubMed  Google Scholar 

  60. Schreiber S, Lawrance IC, Thomsen OO, Hanauer SB, Bloomfield R, Sandborn WJ (2011) Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease—subgroup results from a placebo-controlled study. Aliment Pharmacol Ther 33(2):185–193. doi:10.1111/j.1365-2036.2010.04509.x

    Article  CAS  PubMed  Google Scholar 

  61. Kubota M, Hirayama Y, Okuyama N (2010) Usefulness of bFGF spray in the treatment of perianal abscess and fistula-in-ano. Pediatr Surg Int 26(10):1037–1040. doi:10.1007/s00383-010-2664-8

    Article  PubMed  Google Scholar 

  62. Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52(1):79–86. doi:10.1007/DCR.0b013e3181973487

    Article  PubMed  Google Scholar 

  63. Molendijk I, Bonsing BA, Roelofs H, Peeters KC, Wasser MN, Dijkstra G, van der Woude CJ, Duijvestein M, Veenendaal RA, Zwaginga JJ, Verspaget HW, Fibbe WE, van der Meulen-de Jong AE, Hommes DW (2015) Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease. Gastroenterology 149 (4):918-927 e916. doi:10.1053/j.gastro.2015.06.014

  64. Panes J, Garcia-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S, Collaborators ACSG (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388(10051):1281–1290. doi:10.1016/S0140-6736(16)31203-X

    Article  PubMed  Google Scholar 

  65. Panes J (2016) Stem cell therapy for perianal fistulas in crohn’s disease. Gastroenterol Hepatol (N Y) 12(10):637–640

    Google Scholar 

  66. Singer NG, Caplan AI (2011) Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6:457–478. doi:10.1146/annurev-pathol-011110-130230

    Article  CAS  PubMed  Google Scholar 

  67. DelaRosa O, Dalemans W, Lombardo E (2012) Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Curr Opin Biotechnol 23(6):978–983. doi:10.1016/j.copbio.2012.05.005

    Article  CAS  PubMed  Google Scholar 

  68. Whitehead SM, Leach RD, Eykyn SJ, Phillips I (1982) The aetiology of perirectal sepsis. Br J Surg 69(3):166–168

    Article  CAS  PubMed  Google Scholar 

  69. Grace RH, Harper IA, Thompson RG (1982) Anorectal sepsis: microbiology in relation to fistula-in-ano. Br J Surg 69(7):401–403

    Article  CAS  PubMed  Google Scholar 

  70. Henrichsen S, Christiansen J (1986) Incidence of fistula-in-ano complicating anorectal sepsis: a prospective study. Br J Surg 73(5):371–372

    Article  CAS  PubMed  Google Scholar 

  71. Lunniss PJ, Phillips RK (1994) Surgical assessment of acute anorectal sepsis is a better predictor of fistula than microbiological analysis. Br J Surg 81(3):368–369

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeremy Sugrue.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugrue, J., Nordenstam, J., Abcarian, H. et al. Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review. Tech Coloproctol 21, 425–432 (2017). https://doi.org/10.1007/s10151-017-1645-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-017-1645-5

Keywords

Navigation